Clinical Trials Browser

INDUSTRY × Hodgkin Disease × camrelizumab × Clear all

NCT03155425 2024-02-01

PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma

Phase 2 Completed

75 enrolled 10 charts

Hodgkin Disease